Thrombolytic drug

Revision as of 18:47, 15 November 2013 by Gerald Chi (talk | contribs) (→‎See also)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Thrombolytic drug

Articles

Most recent articles on Thrombolytic drug

Most cited articles on Thrombolytic drug

Review articles on Thrombolytic drug

Articles on Thrombolytic drug in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Thrombolytic drug

Images of Thrombolytic drug

Photos of Thrombolytic drug

Podcasts & MP3s on Thrombolytic drug

Videos on Thrombolytic drug

Evidence Based Medicine

Cochrane Collaboration on Thrombolytic drug

Bandolier on Thrombolytic drug

TRIP on Thrombolytic drug

Clinical Trials

Ongoing Trials on Thrombolytic drug at Clinical Trials.gov

Trial results on Thrombolytic drug

Clinical Trials on Thrombolytic drug at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Thrombolytic drug

NICE Guidance on Thrombolytic drug

NHS PRODIGY Guidance

FDA on Thrombolytic drug

CDC on Thrombolytic drug

Books

Books on Thrombolytic drug

News

Thrombolytic drug in the news

Be alerted to news on Thrombolytic drug

News trends on Thrombolytic drug

Commentary

Blogs on Thrombolytic drug

Definitions

Definitions of Thrombolytic drug

Patient Resources / Community

Patient resources on Thrombolytic drug

Discussion groups on Thrombolytic drug

Patient Handouts on Thrombolytic drug

Directions to Hospitals Treating Thrombolytic drug

Risk calculators and risk factors for Thrombolytic drug

Healthcare Provider Resources

Symptoms of Thrombolytic drug

Causes & Risk Factors for Thrombolytic drug

Diagnostic studies for Thrombolytic drug

Treatment of Thrombolytic drug

Continuing Medical Education (CME)

CME Programs on Thrombolytic drug

International

Thrombolytic drug en Espanol

Thrombolytic drug en Francais

Business

Thrombolytic drug in the Marketplace

Patents on Thrombolytic drug

Experimental / Informatics

List of terms related to Thrombolytic drug

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Thrombolytic drugs are used in medicine to dissolve blood clots in a procedure termed thrombolysis. They limit the damage caused by the blockage of the blood vessel.

Uses

Thrombolysis is used in for myocardial infarction (heart attack), ischemic strokes, deep vein thrombosis and pulmonary embolism to clear a blocked artery and avoid permanent damage to the perfused tissue (e.g. myocardium, brain, leg) and death. A less frequent use is to clear blocked catheters that are used in long-term medical therapy.

It should be noted that thrombolytic therapy in hemorrhagic strokes is contraindicated, as its use in that situation would prolong bleeding into the intracranial space and cause further damage.

Members

The thrombolytic drugs include:

These drugs are most effective if administered immediately after it has been determined they are clinically appropriate. The advantage of administration is highest within the first ninety minutes, but may extend up to six hours after the start of symptoms.

The drugs are often given in combination with intravenous heparin, or low molecular weight heparin, which are anticoagulant drugs.

Side-effects

Hemorrhagic stroke is a rare but serious complication of thrombolytic therapy. If a patient has had thrombolysis before, an allergy against the thrombolytic drug may have developed (especially after streptokinase). If the symptoms are mild, the infusion is stopped and the patient is commenced on an antihistamine before infusion is recommenced. Anaphylaxis generally requires immediate cessation of thrombolysis.

See also

Template:Major Drug Groups


Template:WikiDoc Sources